Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 72.00
0.00 (0.00%)
Oct 8, 2026, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 13.56 billion as of October 9, 2026. It is the 16,025th most valuable company in the world and the 596th biggest in Taiwan. Its market cap has decreased by 7.22% in one year.
Market Cap
13.56B
Enterprise Value
14.84B
Revenue
9.20B
Global Rank
Country Rank
#596 Taiwan
PE Ratio
14.77
ChartMarket Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 13.56B, an increase of 442.74%. That is a compound annual growth rate of 7.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 13.56B | -3.12% |
| Dec 31, 2025 | 14.00B | -0.37% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 486.96B |
| Lin BioScience | 149.26B |
| Caliway Biopharmaceuticals | 122.10B |
| Heron Neutron Medical | 83.90B |
| ScinoPharm Taiwan | 14.75B |
| Visco Vision | 14.58B |
| AP Biosciences | 13.85B |
| Lumosa Therapeutics | 13.53B |